These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 11823719

  • 1. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A, Yang Y, Nakada MT, Li Q, Yang T.
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [Abstract] [Full Text] [Related]

  • 2. Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab')2 in a model of focal cerebral ischemia in rats.
    Yang Y, Li Q, Nakada MT, Yang T, Shuaib A.
    J Neurosurg; 2001 Apr; 94(4):582-8. PubMed ID: 11302656
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L, Zhang ZG, Zhang R, Morris D, Lu M, Coller BS, Chopp M.
    Circulation; 2003 Jun 10; 107(22):2837-43. PubMed ID: 12756151
    [Abstract] [Full Text] [Related]

  • 4. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L, Zhang ZG, Zhang C, Zhang RL, Chopp M.
    Stroke; 2004 Dec 10; 35(12):2890-5. PubMed ID: 15514182
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.
    Mickelson JK, Simpson PJ, Cronin M, Homeister JW, Laywell E, Kitzen J, Lucchesi BR.
    Circulation; 1990 Feb 10; 81(2):617-27. PubMed ID: 2105175
    [Abstract] [Full Text] [Related]

  • 6. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor.
    Ding G, Jiang Q, Zhang L, Zhang ZG, Li L, Knight RA, Ewing JR, Wang Y, Chopp M.
    J Cereb Blood Flow Metab; 2005 Jan 10; 25(1):87-97. PubMed ID: 15678115
    [Abstract] [Full Text] [Related]

  • 7. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
    Spriggs D, Gold HK, Hashimoto Y, Van Houtte E, Vermylen J, Collen D.
    Thromb Haemost; 1989 Feb 28; 61(1):93-6. PubMed ID: 2501892
    [Abstract] [Full Text] [Related]

  • 8. Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.
    Yasuda T, Gold HK, Leinbach RC, Saito T, Guerrero JL, Jang IK, Holt R, Fallon JT, Collen D.
    J Am Coll Cardiol; 1990 Dec 28; 16(7):1728-35. PubMed ID: 2123910
    [Abstract] [Full Text] [Related]

  • 9. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y, Li Q, Yang T, Hussain M, Shuaib A.
    J Neurosurg; 2003 Feb 28; 98(2):397-403. PubMed ID: 12593629
    [Abstract] [Full Text] [Related]

  • 10. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
    Rote WE, Mu DX, Bates ER, Nedelman MA, Lucchesi BR.
    J Cardiovasc Pharmacol; 1994 Feb 28; 23(2):194-202. PubMed ID: 7511747
    [Abstract] [Full Text] [Related]

  • 11. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
    Gold HK, Coller BS, Yasuda T, Saito T, Fallon JT, Guerrero JL, Leinbach RC, Ziskind AA, Collen D.
    Circulation; 1988 Mar 28; 77(3):670-7. PubMed ID: 3124974
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
    Sudo Y, Kilgore KS, Lucchesi BR.
    J Cardiovasc Pharmacol; 1995 Aug 28; 26(2):241-50. PubMed ID: 7475049
    [Abstract] [Full Text] [Related]

  • 13. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
    Maeda M, Moriguchi A, Mihara K, Aoki T, Takamatsu H, Matsuoka N, Mutoh S, Goto T.
    J Cereb Blood Flow Metab; 2005 Jan 28; 25(1):108-18. PubMed ID: 15678117
    [Abstract] [Full Text] [Related]

  • 14. Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs.
    Kiss RG, Lu HR, Roskams T, Jang IK, Plow EF, Gold HK, Collen D.
    Arterioscler Thromb; 1994 Mar 28; 14(3):367-74. PubMed ID: 8123640
    [Abstract] [Full Text] [Related]

  • 15. Map-ISODATA demarcates regional response to combination rt-PA and 7E3 F(ab')2 treatment of embolic stroke in the rat.
    Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Ewing JR, Knight RA, Kapke A, Soltanian-Zadeh H, Chopp M.
    J Magn Reson Imaging; 2005 Jun 28; 21(6):726-34. PubMed ID: 15906325
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y, Li Q, Miyashita H, Howlett W, Siddiqui M, Shuaib A.
    J Neurosurg; 2000 May 28; 92(5):841-7. PubMed ID: 10794299
    [Abstract] [Full Text] [Related]

  • 17. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
    Di Pasquale P, Sarullo FM, Cannizzaro S, Vitrano MG, Giubilato A, Scalzo S, Giambanco F, Paterna S.
    Ital Heart J; 2001 Oct 28; 2(10):751-6. PubMed ID: 11721719
    [Abstract] [Full Text] [Related]

  • 18. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M, Asahi K, Wang X, Lo EH.
    J Cereb Blood Flow Metab; 2000 Mar 28; 20(3):452-7. PubMed ID: 10724108
    [Abstract] [Full Text] [Related]

  • 19. Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis.
    Shetler TJ, Crowe VG, Bailey BD, Jackson CV.
    Circulation; 1996 Oct 01; 94(7):1719-25. PubMed ID: 8840866
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
    Gold HK, Gimple LW, Yasuda T, Leinbach RC, Werner W, Holt R, Jordan R, Berger H, Collen D, Coller BS.
    J Clin Invest; 1990 Aug 01; 86(2):651-9. PubMed ID: 2384607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.